Multidisciplinary management of interstitial lung diseases: A real-life study

Multidisciplinary management of interstitial lung diseases: A real-life study

Authors

  • Caroline Biglia Pneumology department, Cliniques universitaires Saint-Luc, Bruxelles, Belgium
  • Benoît Ghaye Radiology department, Cliniques universitaires Saint-Luc, Bruxelles, Belgium
  • Gregory Reychler Pneumology department, Cliniques universitaires Saint-Luc, Bruxelles, Belgium
  • Sandra Koenig Cliniques universitaires Saint-Luc, service de pneumologie, Bruxelles
  • Halil Yildiz General internal medicine department, Cliniques universitaires Saint-Luc, Bruxelles, Belgium
  • Valérie Lacroix Thoracic surgery department, Cliniques universitaires Saint-Luc, Bruxelles, Belgium
  • Farah Tamirou Rheumatology department, Cliniques universitaires Saint-Luc, Bruxelles, Belgium
  • Delphine Hoton Pathology department, Cliniques universitaires Saint-Luc, Bruxelles, Belgium
  • Thierry Pieters Pneumology department, Cliniques universitaires Saint-Luc, Bruxelles, Belgium
  • Antoine Froidure Pneumology department, Cliniques universitaires Saint-Luc, Bruxelles, Belgium

Keywords:

Interstitial lung diseases, multidisciplinary management

Abstract

Background: The guidelines on idiopathic pulmonary fibrosis (IPF) diagnosis established the crucial role of multidisciplinary discussion (MDD) in the diagnosis of interstitial lung diseases (ILD). However, real-life evaluation of MDD remains scarce. Our aim was to study the impact of a well-structured MDD on etiological assessment, diagnosis, and management of ILD. Methods: We collected and analysed all relevant data on patients concerning diagnosis and treatment before and after MDD during the year 2017. Results: One hundred fifty patients were included in the analysis. MDD had a significant impact on management: 42% of diagnoses were revised and the number of unclassifiable ILD was significantly reduced. Lung biopsy was performed in 26 patients (12 cryobiopsies and 14 surgical biopsies). The most prevalent diagnoses were connective-tissue disease associated ILD (32%), idiopathic pulmonary fibrosis (23%), hypersensitivity pneumonitis (13%) and granulomatous ILD (7%). MDD led to a change or initiation of treatment in 55% of cases. Nine patients were evaluated for transplantation, 23 patients were screened for academic or sponsored clinical trials and an 8-fold increase in rehabilitation inclusion was observed. Conclusion: Our results confirm the benefits of MDD on ILD management and diagnosis. MDD also facilitates access to non-pharmacological therapies and clinical trials.

Published

06-06-2019

Issue

Section

Original Articles: Clinical Research

How to Cite

1.
Biglia C, Ghaye B, Reychler G, Koenig S, Yildiz H, Lacroix V, et al. Multidisciplinary management of interstitial lung diseases: A real-life study. Sarcoidosis Vasc Diffuse Lung Dis [Internet]. 2019 Jun. 6 [cited 2025 Mar. 9];36(2):108-15. Available from: https://mattioli1885journals.com/index.php/sarcoidosis/article/view/8107